Finepoint Capital

Latest statistics and disclosures from Finepoint Capital's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are SPY, SOXX, QQQ, QXO, RXO, and represent 99.96% of Finepoint Capital's stock portfolio.
  • Added to shares of these 3 stocks: SOXX (+$483M), QQQ (+$366M), RXO (+$10M).
  • Started 2 new stock positions in SOXX, QQQ.
  • Reduced shares in these 4 stocks: IWM (-$398M), SPY (-$337M), QXO (-$142M), SLDB (-$5.4M).
  • Sold out of its positions in IWM, SLDB.
  • Finepoint Capital was a net seller of stock by $-23M.
  • Finepoint Capital has $2.0B in assets under management (AUM), dropping by -2.55%.
  • Central Index Key (CIK): 0001608126

Tip: Access up to 7 years of quarterly data

Positions held by Finepoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Finepoint Capital

Finepoint Capital holds 9 positions in its portfolio as reported in the March 2026 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) 35.1 $686M -32% 1.1M 650.34
 View chart
Ishares Tr Ishares Semicdtr Put Option (SOXX) 24.7 $483M NEW 1.5M 328.66
 View chart
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ) 18.8 $366M NEW 635k 577.18
 View chart
Qxo Com New (QXO) 13.8 $269M -34% 14M 19.42
 View chart
Rxo Common Stock (RXO) 7.5 $147M +7% 10M 14.62
 View chart
Aleanna *w Exp 12/13/202 (ANNAW) 0.0 $397k 490k 0.81
 View chart
Aleanna Com Cl A (ANNA) 0.0 $230k 28k 8.29
 View chart
Moneyhero *w Exp 09/13/202 (MNYWW) 0.0 $76k 895k 0.09
 View chart
Calidi Biotherapeutics (CLDI) 0.0 $249.038000 1.0k 0.24
 View chart

Past Filings by Finepoint Capital

SEC 13F filings are viewable for Finepoint Capital going back to 2014

View all past filings